Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 11:13 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2233–2256 of 48,567 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: AS+ Clear all

Conditions: Multiple Sclerosis, Relapsing-remitting Multiple Sclerosis (RRMS)
Interventions: High Definition transcranial Direct Current Stimulation, Sham High Definition transcranial Direct Current Stimulation; Device
Lead sponsor: The University of Texas at Dallas; Other
Eligibility: 18 Years to 64 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Richardson, Texas

Conditions: Stem Cell Transplant Complications, Graft Vs Host Disease, Myeloid Leukemia, Acute, Myeloid Leukemia in Relapse (Disorder), Myelodysplastic Syndromes
Interventions: Radiation, Fludarabine, Thiotepa, Cyclophosphamide, Mesna, Treg-enriched donor cell, Unmodified donor T Cell, CD34+ Haplo Peripheral Blood Stem Cell, Melphalan; Radiation · Drug · Biological + 1 more
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years to 75 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Parkinson Disease (PD)
Interventions: GET Up PD, Stretching and Flexibility; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 50 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Cerebral Palsy
Interventions: Permobil Explorer Mini, MORE-PT; Device · Other
Lead sponsor: University of Washington; Other
Eligibility: 12 Months to 33 Months
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 2
States / cities: Grand Rapids, Michigan • Portland, Oregon

Conditions: Kōmmour Prenatal Among Marshallese Pregnant Women
Interventions: Kōmmour Prenatal; Behavioral
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years and older · Female only
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Fayetteville, Arkansas

Conditions: Healthy
Interventions: Anthrax Vaccine Adsorbed, Saline injection; Biological
Lead sponsor: Centers for Disease Control and Prevention; Federal
Eligibility: 18 Years to 61 Years
Enrollment: 1,564 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2010
U.S. locations: 5
States / cities: Birmingham, Alabama • Atlanta, Georgia • Silver Spring, Maryland + 2 more

Conditions: Opioid-use Disorder
Interventions: Buprenorphine Naloxone; Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 80 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Obesity & Overweight, Sarcopenia
Interventions: High Protein Diet Counceling, Standard Protein Diet Counceling, Protein Supplement, Supervised Exercise; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 50 Years to 75 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Psychosis Associated With Alzheimer's Disease
Interventions: ML-007C-MA, Placebo; Drug
Lead sponsor: MapLight Therapeutics; Industry
Eligibility: 55 Years to 90 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 38
States / cities: Phoenix, Arizona • Scottsdale, Arizona • Tucson, Arizona + 31 more

Conditions: Knee Pain
Interventions: Genicular nerve block with bupivacaine and corticosteroids, Standard of Care; Procedure · Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 4
States / cities: Philadelphia, Pennsylvania

Conditions: Asthma
Interventions: Nebulized Budesonide, Usual care (albuterol with or without oral steroid); Drug
Lead sponsor: Deborah Gentile; Other
Eligibility: 1 Year to 8 Years
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2009
U.S. locations: 2
States / cities: Bellevue, Pennsylvania • Pittsburgh, Pennsylvania

Conditions: Gulf War Illness, Depression
Interventions: Transcranial Magnetic Stimulation, Sham Transcranial Magnetic Stimulation; Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 204 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 3
States / cities: Palo Alto, California • San Diego, California • Decatur, Georgia

Conditions: Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Interventions: NNC6019-0001, Placebo (NNC6019-0001); Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years and older
Enrollment: 1,280 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 63
States / cities: Phoenix, Arizona • La Jolla, California • Los Angeles, California + 49 more

Conditions: Painful Diabetic Neuropathy (PDN), Peripheral Neuropathy With Type 2 Diabetes, Vegan Diet
Interventions: Diet, Medical management; Other
Lead sponsor: AdventHealth; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Hendersonville, North Carolina

Conditions: Diabetes Mellitus, Type 2
Interventions: Peers LEAD plus HLWD; Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 20 Years to 90 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Brain Concussion
Interventions: Scheduled telephone follow-up; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 16 Years to 80 Years
Enrollment: 366 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2006
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Hematopoietic and Lymphoid Cell Neoplasm, Refractory Lymphoma, Refractory Malignant Solid Neoplasm, Refractory Multiple Myeloma
Interventions: Binimetinib; Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Old Age; Debility, Peripheral Neuropathy
Interventions: Protective Arm Balance Response Training; Behavioral
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 45 Years to 88 Years
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: MYOPATHY
Interventions: Hematopoietic stem cell transplantation, Cyclophosphamide, Mesna, ATG(rabbit), Methylprednisolone, G-CSF, Rituxan; Biological · Drug
Lead sponsor: Northwestern University; Other
Eligibility: 16 Years to 65 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2016
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Family Caregivers, Stroke
Interventions: Telephone Assessment and Skill-Building Kit (TASK III) Group, Information Support and Referral (ISR) Group; Behavioral
Lead sponsor: University of Cincinnati; Other
Eligibility: 21 Years and older
Enrollment: 74 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Speech Perception
Interventions: Audiovisual speech training in noise for children; Other
Lead sponsor: Smarty Ears; Industry
Eligibility: 8 Years to 12 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 2
States / cities: New Haven, Connecticut • Hampton, Virginia

Conditions: Long COVID, Chronic Fatigue Syndrome
Interventions: Transcutaneous Non-Invasive Vagus Nerve Stimulation; Device
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: Up to 70 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Non Hodgkin Lymphoma, Solid Tumor
Interventions: SB-4826, Rituximab; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2033
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Prostate Cancer
Interventions: SUPR-SABR treatment; Radiation
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older · Male only
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Charleston, South Carolina

Search by objective public record fields.

Non-invasive Brain Stimulation to Improve Memory in Multiple Sclerosis

IS-free Treg HaploHCT

Behavioral Intervention for Lifestyle Physical Activity in Parkinson's Disease

Dynamic, Real-world Learning, Innovative Mobility, and Versatile Exploration (DRIVE): Evaluating a Dose-matched Developmental Powered Mobility Intervention for Young Children With Cerebral Palsy

Exploring the Feasibility of Kōmmour Prenatal to Reduce Maternal and Infant Health Disparities

Anthrax Vaccine Clinical Trial to Assess Dose Reduction and Route Change

Buprenorphine Loading in the Emergency Department

Optimizing Adaptive Intensive Behavioral Therapy for Obesity During the Transition to Older Adulthood

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

Genicular Nerve Block for Knee Pain in the ED

Effect of Nebulized Budesonide and Oral Corticosteroids on Wheezing Episode Relapse in Children

rTMS in Alleviating Pain and Co-Morbid Symptoms in Gulf War Veterans Illness (GWVI)

CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

The Treatment of Painful Diabetic Neuropathy With Diet

Peers LEAD Plus Healthy Living With Diabetes (HLWD)

Telephone Follow-Up on Outcome After Mild Traumatic Brain Injury

Testing Binimetinib as a Potential Targeted Treatment in Cancers With NRAS Genetic Changes (MATCH-Subprotocol Z1A)

Protective Arm Balance Responses

Stem Cell Transplantation in Idiopathic Inflammatory Myopathy Diseases

Caregiver Self-Management Needs Through Skill-Building

Improving Perception of Speech in Noise in Children With Communication Disorders

Vagus Nerve Stimulation as Treatment for Long Covid

SB-4826 in Adult Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphomas

Stereotactic Ablative Radiation Therapy for Prostate Cancer